An open-label, single-arm phase 2 study evaluating efficacy and safety of intralesional PV-10 followed by external beam radiotherapy (XRT) in patients with transit or recurrent metastatic melanoma

Trial Profile

An open-label, single-arm phase 2 study evaluating efficacy and safety of intralesional PV-10 followed by external beam radiotherapy (XRT) in patients with transit or recurrent metastatic melanoma

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2017

At a glance

  • Drugs Rose bengal sodium (Primary)
  • Indications Malignant melanoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
    • 01 Jun 2016 New trial record
    • 19 May 2016 Results published in Provectus Biopharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top